UniSa - IRIS Institutional Research Information System

PICILLO, Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.085
EU - Europa 2.074
AS - Asia 1.811
SA - Sud America 381
OC - Oceania 29
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.399
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.052
SG - Singapore 773
CN - Cina 507
IT - Italia 502
RU - Federazione Russa 454
BR - Brasile 354
UA - Ucraina 326
IE - Irlanda 218
DE - Germania 179
TR - Turchia 150
VN - Vietnam 146
SE - Svezia 137
KR - Corea 103
EE - Estonia 69
FI - Finlandia 57
HK - Hong Kong 50
GB - Regno Unito 38
IN - India 29
NL - Olanda 23
CA - Canada 21
AU - Australia 19
CZ - Repubblica Ceca 17
AT - Austria 14
FR - Francia 13
NZ - Nuova Zelanda 10
BD - Bangladesh 8
AR - Argentina 7
EC - Ecuador 6
IQ - Iraq 6
JP - Giappone 6
MX - Messico 6
PL - Polonia 5
EU - Europa 4
IL - Israele 4
KE - Kenya 4
MA - Marocco 4
NP - Nepal 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
ES - Italia 3
LU - Lussemburgo 3
PK - Pakistan 3
VE - Venezuela 3
ZA - Sudafrica 3
BO - Bolivia 2
CL - Cile 2
CO - Colombia 2
GE - Georgia 2
GR - Grecia 2
ID - Indonesia 2
JM - Giamaica 2
MK - Macedonia 2
NO - Norvegia 2
PA - Panama 2
PY - Paraguay 2
SA - Arabia Saudita 2
UY - Uruguay 2
AL - Albania 1
BG - Bulgaria 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
Totale 9.399
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.168
Princeton 612
Chandler 520
Wilmington 468
Jacksonville 408
Houston 290
Singapore 269
Dublin 213
Ashburn 200
Woodbridge 180
Dong Ket 144
Izmir 142
Moscow 122
Andover 117
Nanjing 109
Beijing 101
Naples 94
Boardman 82
Pellezzano 76
Tallinn 69
Salerno 66
Norwalk 62
Hong Kong 49
Dearborn 46
Düsseldorf 46
Shenyang 44
Fairfield 37
Redwood City 37
West Jordan 35
Mestre 34
Changsha 32
Nanchang 32
Hebei 27
Pune 25
Jiaxing 22
Rome 21
Dallas 19
Nuremberg 18
São Paulo 16
Milan 15
San Diego 15
Tianjin 15
Belo Horizonte 14
Lecce 14
Los Angeles 14
Rio de Janeiro 14
Brasília 13
Washington 13
Council Bluffs 12
Brno 11
Guangzhou 11
Amsterdam 10
Seattle 10
Cambridge 8
Curitiba 8
Lappeenranta 8
Shanghai 8
Sydney 8
Ottawa 7
Ribeirão Preto 7
Fort Worth 6
Jinan 6
Kunming 6
San Francisco 6
Santa Clara 6
Wuhan 6
Auckland 5
Bologna 5
Carapicuíba 5
Casoria 5
Fuzhou 5
Guarulhos 5
Napoli 5
Orange 5
Perugia 5
Santa Maria A Vico 5
Springfield 5
São Bernardo do Campo 5
Assago 4
Campinas 4
Dhaka 4
Dormagen 4
Fortaleza 4
Helsinki 4
Melbourne 4
Munich 4
Nairobi 4
New York 4
Romano di Lombardia 4
Sorocaba 4
Angra dos Reis 3
Anápolis 3
Baghdad 3
Betim 3
Brussels 3
Campos dos Goytacazes 3
Clifton 3
Duque de Caxias 3
Feira de Santana 3
Fisciano 3
Totale 6.461
Salva come PNG Salva come JPEG
Nome #
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 139
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 127
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 125
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 110
Increased bilirubin levels in de novo Parkinson's disease 109
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 106
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 105
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 97
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 96
Gender and non motor fluctuations in Parkinson's disease: A prospective study 94
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 93
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 93
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 91
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 91
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 91
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 89
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 89
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 88
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 88
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Sep;132(Pt 9):2350-5. PMID: 19584099 86
The relevance of gender in Parkinson's disease: a review 85
PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family 85
Quitting smoking: An early non-motor feature of Parkinson's disease? 84
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 84
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 84
Early MRI findings in acquired hepatocerebral degeneration. 83
Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale 83
Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards 82
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 81
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 81
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 81
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 80
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 80
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 78
Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family 78
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 76
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 76
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 75
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 75
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 75
Uric acid relates to dopamine transporter availability in Parkinson's disease. 74
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 74
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 74
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 74
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 73
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 73
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 73
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 73
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 71
Patients with Parkinson?s disease and scans with (predominant) ipsilateral dopaminergic deficit 70
Evolution of mild cognitive impairment in Parkinson disease 70
Deep Brain Stimulation Target Selection for Parkinson's Disease 70
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 69
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 68
Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy 68
Non-motor correlates of smoking habits in de novo Parkinson's disease 68
Resting brain networks in patients with Parkinson's disease and freezing of gait 67
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 67
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 66
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 65
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 65
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 64
Biomarkers of Parkinson's disease: recent insights, current challenges, and future prospects 63
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 60
Progressive Parkinsonism, Balance Difficulties, and Supranuclear Gaze Palsy 60
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 60
Freezing of gait and executive functions in patients with Parkinson's disease. 59
Recent advances in Essential Tremor: Surgical treatment 59
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 58
Progression of striatal and extrastriatal degeneration in multiple systematrophy: a longitudinal diffusion-weighted MR study 57
Teaching NeuroImages: Pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 57
Comparative neuropsychological profile of pathological gambling, hypersexuality and compulsive eating in Parkinson’s disease. 57
Dopamine receptor agonists and depression in Parkinson's disease. 56
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study 56
Medical Management of Parkinson's Disease after Initiation of Deep Brain Stimulation 56
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 55
Hepatitis C virus-related hepatic myelopathy after treatment with Sofosbuvir and Ribavirin: A case report 55
Subdural continuous theta burst stimulation of the motor cortex in essential tremor 54
Establishing a Standard of Care for Deep Brain Stimulation Centers in Canada 53
Serum IGF-1 is associated with cognitive functions in early, drug-naive Parkinson's disease 52
The use of smell identification test in Parkinson's disease in Italy: Preliminary data 52
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 52
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 51
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 51
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 51
Neuropsychiatric disturbances in parkinsonian patients with and without freezing of gait 50
Midbrain MRI assessments in progressive supranuclear palsy subtypes 50
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 49
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 49
Loss of cutaneous large and small fibers in naive and l -dopa-treated PD patients 48
When shaking during standing points to hereditary spastic paraplegias 48
Programming Deep Brain Stimulation for Tremor and Dystonia: The Toronto Western Hospital Algorithms 47
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 47
Diffusion-weighted imaging in multiple system atrophy: a comparison betweenclinical subtypes 46
Two indications, one target: Concomitant epilepsy and Tourettism treated with Centromedian/parafascicular thalamic stimulation 46
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 46
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 46
Medical Management of Movement Disorders. 45
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 45
Genetic Screening for the LRRK2 R1441C and G2019S Mutations in Parkinsonian Patients from Campania. 44
Totale 7.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.703
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020202 0 0 0 0 0 0 0 0 0 0 177 25
2020/2021733 8 51 57 4 106 64 90 5 72 5 84 187
2021/2022956 11 3 6 12 11 4 18 34 132 117 138 470
2022/20231.387 183 95 70 109 180 309 16 125 189 9 72 30
2023/2024947 52 116 44 65 34 113 42 83 61 78 79 180
2024/20252.052 84 26 46 164 106 233 341 248 465 315 24 0
Totale 9.870